Suppression of Mycobacterium tuberculosis induced reactive oxygen species (ROS) and TNF-α mRNA expression in human monocytes by allicin  by Hasan, Nazarul et al.
FEBS Letters 580 (2006) 2517–2522Suppression of Mycobacterium tuberculosis induced reactive
oxygen species (ROS) and TNF-a mRNA expression in human
monocytes by allicin
Nazarul Hasana, Nabiha Yusufb, Zahra Toossic, Najmul Islama,*
a Department of Biochemistry, Faculty of Medicine, J.N. Medical College, A.M.U., Aligarh 202002, U.P., India
b Department of Dermatology, University of Birmingham, Birmingham, AL, USA
c Division of Infectious Diseases, Department of Medicine, Case Western Reserve University, Cleveland, OH, USA
Received 27 January 2006; revised 7 March 2006; accepted 20 March 2006
Available online 7 April 2006
Edited by David LambethAbstract Chronic inﬂammation associated with tumor necrosis
factor (TNF)-a and reactive oxygen species (ROS) is the hall-
mark of tuberculosis. Mycobacterium tuberculosis (MTB) di-
rectly stimulates human monocytes to secrete TNF-a. We
show the augmented expression of TNF-a mRNA in MTB-in-
fected monocytes by cellular activation and ROS was suppressed
by allicin in a dose-dependent manner. Also, allicin enhanced the
glutathione peroxidase activity, which correlated inversely with
the downregulation of ROS and TNF-a in MTB-infected mono-
cytes. Hence, allicin may prove to be a valuable natural antiox-
idant in combating tuberculosis.
 2006 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The involvement of tumor necrosis factor (TNF)-a recog-
nized as a signiﬁcant mediator of macrophage activation for
intracellular killing of Mycobacterium tuberculosis (MTB) ba-
cilli following ingestion by phagocytic cells has been reported
[1–3]. Both beneﬁcial and deleterious eﬀects of TNF-a to host
contributing to the pathophysiology of tuberculosis have been
observed [4]. Therefore, an understanding of the mechanisms
that regulate TNF-a expression is important in achieving a
harmonious balance between the outcome of both its beneﬁcial
and pathologic eﬀects. Dietary supplementation in anti-tuber-
culosis therapy is relevant as a safe and economic option,
where garlic (Allium sativum L.) has been proposed as an eﬀec-
tive herbal therapeutic, as it is a strong antioxidant and anti-
inﬂammatory agent [5,6] having beneﬁcial eﬀects on immune
system [7].
The present study focuses on allicin, the main biologically
active component of freshly crushed garlic, as a potential agent
to counteract the pathological eﬀects of increased TNF-a pro-
duction in tuberculosis infection. A variety of biological eﬀects
of allicin are attributed both to its SH-modifying and antioxi-*Corresponding author. Fax: +91 571 2721776.
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may also be a target of allicin [5,10]. Also, garlic has been re-
ported to scavenge O2 , H2O2 and OH in a concentration-
dependent manner [11]. Earlier studies involving allicin at
higher concentrations have proven to be toxic [9]. Thus, in
the present study a lower non-toxic concentration of allicin
(500 ng/ml) was used to control the increased TNF-a produc-
tion in MTB-infected human monocytes as well as to investi-
gate the potential mechanism involved in downregulating
TNF-a, which in turn may help in understanding the use of
allicin in tuberculosis therapy.2. Materials and methods
2.1. Materials
H37Rv strain of MTB was from J.N. Medical College, Aligarh. Re-
combinant human (rh) TNF-a, monoclonal anti-TNF-a antibody, N-
acetyl-cysteine (NAC), H2O2, SN50 and its analogue SN50/M and try-
pan blue were purchased from Sigma–Aldrich (St. Louis, MO, USA).
Ficoll-Paque was from Pharmacia (LKB Biotechnology Piscataway,
NJ). Allicin was of LKT Laboratories Inc. (St. Paul, MN, USA). All
other chemicals were of the highest purity grade available. SN50 is a
hybrid peptide containing nuclear localization sequence of p50 subunit
of NF-jB heterodimer and has been shown to completely inhibit the
translocation of NF-jB in human cell lines at 100 lg/ml [23]. Blood
was obtained from healthy, non-smoking volunteers of 20–40 years
of age.2.2. Viability assessment of monocytes
The eﬀect of allicin (0–500 ng/ml) on monocyte viability was assessed
by MTT Cell Viability Assay Kit (R&D Systems) according to manu-
facturer’s instructions. The percentage of viable cells was calculated by
the formula as described previously [12]. Results were expressed as
‘‘viable cells (% of control cells)’’. Also, eﬀects of allicin, if any, were
probed by analyzing the housekeeping genes like b-actin by reverse
transcription (RT)-PCR and R18 by quantitative real-time RT-PCR.
In addition, viability was also ascertained using trypan blue exclusion
test [13].2.3. Preparation of PBMC and cell culture
Blood was collected by venipuncture in heparinized syringes and
PBMC (peripheral blood mononuclear cells) were isolated by density
gradient sedimentation on Ficoll-Paque separation medium [14].
PBMC (5 · 106 cells/well) were added in 12-well tissue culture plates
(Costar Corp., Cambridge, MA) in complete RPMI-1640 medium,
and were subsequently incubated at 37 C, 5% CO2 for 1–2 h for
adherence. Non-adherent cells were washed away with RPMI medium,
and adherent monocytes were rested overnight in RPMI having 2%
serum at 37 C, 5% CO2.ation of European Biochemical Societies.
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Mid-log cultures of MTB (H37Rv) grown in Middlebrook 7H9 broth
(HiMedia, India) and quantiﬁed by CFU assay were used for infection
[14,15]. Adherant monocytes (MNs) were infected with MTB at 1:1
(bacteria/cell) in 30% autologous serum for 90 min at 37 C, 5%
CO2, followed by washing (4·) with RPMI-1640 medium. Cells har-
vested at this time point were considered as time zero after infection
(t0). Other cultures received RPMI-1640 medium with 2% autologous
serum. Some cultures immediately after infection received 10 ng/ml
rhTNF-a, 10 ng/ml anti-TNF-a antibodies, varying doses of allicin
(0–500 ng/ml) and a mixture of 10 ng/ml TNF-a and 500 ng/ml allicin,
respectively. Also, some cultures received 10 nmol/l H2O2, 10 mmol/l
NAC, 100 lg/ml SN50 and SN50/M. Cultures were harvested after
24 h and cells were lysed in 0.5 ml of TRIZOL Reagent (Invitrogen
Inc., Carlsbad, CA).
2.5. Isolation of total RNA/messenger RNA and reverse transcription
Total RNA or messenger RNA (mRNA) was isolated from unin-
fected as well as infected monocytes as per manufacture’s speciﬁcations
(Qiagen, Valencia, CA). Total RNA or mRNA was reverse-transcribed
using SuperScript II reverse transcriptase (Life Technologies, Gibco
BRL, Gaithersburg, MD). Primers (Stratagene, La Jolla, CA) and
RT-PCR conditions followed protocols supplied by the manufacturer
(Life Technologies, Gibco BRL).
2.6. Quantitative real-time RT-PCR
Quantitative real-time RT-PCR with internal ﬂuorescent hybridiza-
tion probes in the ABI Prism 7700 Detection System (ABI, Foster City,
CA) was employed to quantify host TNF-a gene transcription. This
technique aﬀords a sensitive and speciﬁc quantiﬁcation of individual
RNA transcripts [16]. Human R18 housekeeping gene was employed
to normalize gene expression. TaqMan PCR primers and probes as
well as target-speciﬁc RT primer for each assay were designed as de-
scribed elsewhere [14,17].
The primer and probe sequences used as depicted below have been
previously reported [17]. R18 – RT primer: GACGGTATCTGATC;
reverse primer: 5 0-CAT TCT TGG CAA ATG CTT TC-30; forward
primer: 5 0-CGC CGC TAG AGG TGA AAT TC-30; TaqMan probe:
5 0-6FAM-ACC GGC GCA AGA CGG ACC AGA-TAMRA-3 0.
TNF-a – RT primer: GGTTTCTACAACA; reverse primer: 5 0-GTTC-
GAGAAGATGATCTGACTGCC-3 0; forward primer: 5 0-AGGCGG-
TGCTTGTTCCTCA-3 0; TaqMan probe: 5 0-6FAM-CCAGAGGGA-
AGAGTTCCCCAGGGAC-TAMRA-30.
All probes were labeled with 5-carboﬂuorescein (FAM) at the 5 0 end
and N 0,N 0,N 0,N 0-tetramethy-6-carborhodamine (TAMRA) at the 3 0
end (PE). The proximity of the dye (FAM) and the quencher (TAM-
RA) on the intact probe prevents detection of any ﬂuorescence. How-
ever, degradation of the probe during the course of PCR allows the
release and detection of FAM [18]. The PCRs for all ampliﬁcations
were similar: 5 ll of each cDNA, 20 ll of Taqman Universal PCR
Master Mix (PE Biosystems), which contains optimal amounts of
AmpliTaq Gold DNA polymerase (which protects against amplicon
carryover) and of dNTPs, and optimal amounts of probe and primers
calibrated to allow measurement of the targets. First, cDNA was syn-
thesized in the presence of 0.5 ll of murine leukemia virus enzyme
(Invitrogen)/reaction and 10 lmol/l of each RT primer, dNTPs, and
other substrate. Conditions for PCR were similar for all products
(1 cycle of 2 min at 50 C and 1 cycle of 10 min at 95 C and then 40
cycles of 15 s at 95 C and 1 min at 60 C). The cycle threshold for each
sample was compared with the cycle threshold values of known
amounts of a standard DNA constructed for each target and ampliﬁed
simultaneously.
To assure lack of DNA contamination in the RNA samples, in some
experiments, a duplicate tube of sample with no RT enzyme was in-
cluded as control. DNA contamination remained negligible. In each
sample, host 18S ribosomal RNA was used as internal control. Expres-
sion of TNF-a mRNA was corrected to internal control (host 18S
rRNA) in the same sample and was expressed as copies of TNF-a in
1010 copies of R18 (equivalent to 1 · 106 monocytes).2.7. Glutathione peroxidase assay
The activity of glutathione peroxidase (GPx) was measured as
described elsewhere [19]. Brieﬂy, MTB-infected monocytes were co-cul-
tured for 24 h with or without 10 mmol/l NAC, 100 lg/ml SN50,100 lg/ml SN50/M and 500 ng/ml allicin in the presence or absence
of 10 nmol/l H2O2. Thereafter, cells were scrapped, sonicated and cen-
trifuged as described earlier [19], and the supernatants were subjected
to GPx activity determination. The GPx activity was quantiﬁed in
100 ll of each sample, with continuous photometric monitoring of oxi-
dized glutathione (GSSG) at 37 C. The conversion of NADPH to
NADP was evaluated using UV absorbance at 340 nm [20]. GPx activ-
ity was calculated after subtraction of the blank value, as lmol of
NADPH oxidized/min/mg protein (U/mg protein).
2.8. Statistical analysis
Results were analyzed by use of paired t test and expressed as
means ± S.E. of six experiments. P < 0.05 was considered statistically
signiﬁcant.3. Results
3.1. Toxicity versus allicin
Since higher doses of allicin are toxic [9], thus lower concen-
trations (0–500 ng/ml) were employed, which failed to show
any eﬀect on monocytes by MTT (Fig. 1A) or trypan blue
exclusion assays. Cell viability is expressed as percent mean
(±S.E.) viable cells compared to untreated cells (taken as
100% viable). Also, no eﬀect was observed on housekeeping
genes like b-actin gene as revealed by RT-PCR (Fig. 1B) or
R18 gene (18S rRNA) by quantitative real-time RT-PCR
(Fig. 1C), thereby indicating that allicin did not non-speciﬁ-
cally aﬀect human TNF-a transcription
3.2. Dose–response eﬀect of allicin on TNF-a gene expression
MTB-infected monocytes were co-cultured for 24 h with
varying doses of allicin. Infected/uninfected cultures devoid
of allicin served as controls. The eﬀect of allicin (0–500 ng/
ml) on the ampliﬁcation of TNF-a gene was dose-dependent,
where 250 and 500 ng/ml allicin proved to be potent inhibitor
as evident from RT-PCR products (Fig. 2A). This was further
substantiated by real-time RT-PCR, where in comparison to
control, a linear downregulation of TNF-a mRNA copy num-
bers by 3.2 logs (P < 0.001), 4.1 logs (P < 0.001), 7.1 logs
(P < 0.001) and 8.1 logs (P < 0.001) was recorded with 50,
100, 250 and 500 ng/ml of allicin, respectively (Fig. 2B). Thus,
allicin potently inhibits the pro-inﬂammatory cytokine
TNF-a.
3.3. Modulation studies of endogenous TNF-a mRNA
In comparison to control uninfected monocytes, endoge-
nous TNF-a mRNA in infected monocytes augmented to
the order of 10.1 logs (P < 0.01), which enhanced further
by 4 logs (P < 0.05) with exogenous rhTNF-a (Fig. 3A).
The eﬀect of exogenous rhTNF-a was neutralized substan-
tially by anti-TNF-a antibody or 500 ng/ml allicin as is evident
by suppression between 8.1 logs and 8.3 logs (P < 0.01) in
endogenous TNF-a mRNA expression. No eﬀect was ob-
served in uninfected monocytes that were either treated or un-
treated with 500 ng/ml of allicin for 24 h (Fig. 3A). A
suppression in endogenous TNF-a mRNA in MTB-infected
monocytes by 6.3 logs (P < 0.001) and 5.2 logs
(P < 0.001) was observed with 500 ng/ml allicin and 10 ng/ml
anti-TNF-a antibody, respectively (Fig. 3A). Similar pattern
was observed with RT-PCR products (Fig. 3B). Thus, TNF-
a is involved in positive auto-regulation, and that, allicin also
proves to be a potent inhibitor of TNF-a like anti-TNF-a
antibody.
Fig. 2. Dose–response eﬀect of allicin (0–500 ng/ml) on (A) ampli-
ﬁcation of TNF-a in MTB-infected monocytes by RT-PCR. The
ampliﬁcation products of TNF-a (342 bp) is shown as: lane (1)
DNA ladder; lanes 2–6 having 0, 50, 100, 250 and 500 ng/ml
allicin, respectively, and (B) expression of TNF-a mRNA by real-
time RT-PCR. Expression of TNF-a was corrected to host 18S
rRNA and expressed as copies of TNF-a in 1010 copies of R18
(equivalent to 1 · 106 monocytes). Data are mean (±S.E.) of 6
experiments.
Fig. 1. (A) MTT cell viability assay for dose–response eﬀect of allicin
(0–500 ng/ml) on MTB-infected monocytes. Data represent the anal-
ysis of three independent experiments in duplicates, expressed as mean
viable cells (±S.E.) percentage of controls. (B) b-Actin RT-PCR.
Dose–response eﬀect of allicin (0–500 ng/ml) on b-actin of MTB-
infected monocytes. The ampliﬁcation product for b-actin (514 bp) is
shown. Lane (1) DNA ladder; lanes 2–6 having 0, 50, 100, 250 and
500 ng/ml allicin, respectively. (C) Real-time quantitative RT-PCR for
human housekeeping R18 gene (18S rRNA), where data are mean
(±S.E.) of 6 experiments.
Fig. 3A. Modulation of TNF-a mRNA expression. Human mono-
cytes were infected with MTB H37Rv (1:1 bacteria/cell). Some cultures
were not infected (MN only and MN + allicin) and served as controls.
Cultures then received either rhTNF-a (10 ng/ml) or rhTNF-a (10 ng/
ml) + anti-TNF-a Abs (10 ng/ml) or rhTNF-a (10 ng/ml) + allicin
(500 ng/ml) or anti-TNF-a Abs (10 ng/ml) or allicin (500 ng/ml) or
media alone () for 24 h. Total RNA was extracted and assessed for
TNF-a mRNA. Data are mean (±S.E.) of 6 experiments.
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NAC, a speciﬁc inhibitor of reactive oxygen species (ROS)
pathway, has been shown in assessing the eﬀects of activation
of ROS on human TNF-a gene expression in infected alveolar
macrophages [17]. Here, comparative antioxidant eﬀect of
NAC versus allicin on TNF-a gene expression was probed,
where NAC and allicin downregulated TNF-a mRNA expres-
sion by around 5.5 logs (P < 0.001) and 6.3 logs (P < 0.001),
respectively, at 24 h (Fig. 4A) as compared to 24 h control cul-tures. Thus, allicin proved to be around 0.8 logs more eﬀective
than NAC. This was further substantiated by dose–response
eﬀects of allicin (Fig. 2B) and NAC (data not shown), where
Fig. 3B. Modulation of TNF-a in MTB-infected monocytes by RT-
PCR. Lanes (1) DNA ladder, (2) rhTNF-a (10 ng/ml), (3) infected
monocytes, (4) anti-TNF-a Abs (10 ng/ml), (5) rhTNF-a (10 ng/
ml) + allicin (500 ng/ml), (6) rhTNF-a (10 ng/ml) + anti-TNF-a Abs
(10 ng/ml) and (7) allicin (500 ng/ml).
Fig. 4A. Eﬀect of inhibition of NF-jB on expression of TNF-a
mRNA. Human monocytes were infected with MTB H37Rv (1:1
bacteria/cell) in the presence or absence () of NAC (10 mmol/l), SN50
(100 lg/ml), SN50/M (100 lg/ml) or allicin (500 ng/ml). Total RNA
was extracted at 24 h and was assessed for expression of TNF-a
mRNA. Data are mean (±S.E.) of 6 experiments.
Fig. 4B. Induction of expression of TNF-a mRNA by oxygen radical.
Human monocytes were infected with MTB H37Rv (1:1 bacteria/cell)
in the presence or absence () of H2O2 (10 nmol/l), NAC (10 mmol/
l) + H2O2 (10 nmol/l), SN50 (100 lg/ml) + H2O2 (10 nmol/l), SN50/M
(100 lg/ml) + H2O2 (10 nmol/l) or allicin (500 ng/ml) + H2O2
(10 nmol/l). Total RNA was extracted at 24 h and was assessed for
expression of TNF-a mRNA. Data are mean (±S.E.) of 6 experiments.
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NAC were calculated to be 170 ng/ml and 1.3 mg/ml, respec-
tively.
Cellular activation, and thereby induction of TNF-a, is
mediated via NF-jB [21,22]. It has been well documented
that TNF-a induced nuclear translocation of NF-jB was
inhibited in SN50 peptide-treated human monocytic cell lines
as demonstrated in EMSA [23]. Thus, we employed SN50, an
inhibitor of NF-jB, to assess the role of NF-jB in the
expression of TNF-a in MTB-infected monocytes. SN50
(100 lg/ml) was added to monocytes 3 min prior to MTB
infection. Control cultures did not receive SN50. At 24 h,
SN50 suppressed endogenous TNF-a mRNA expression in
MTB-infected monocytes by around 6 logs (P < 0.001) in
comparison to control cultures devoid of SN50 pre-treatment
(Fig. 4A). The IC-50 value calculated for TNF-a inhibition in
MTB-infected monocytes by SN50 was 90 lg/ml. To ensure
that cellular inhibition was not non-speciﬁc, we compared
the eﬀect of SN50 with its inactive analogue, SN50/M at
the same concentration. SN50/M did not aﬀect TNF-a
mRNA expression (P > 0.05) (Fig. 4A). Therefore, the in-
creased expression in TNF-a mRNA by MTB is mediated
mainly via NF-jB.
Addition of H2O2 to MTB-infected monocytes resulted in a
further augmentation by 1.2 logs in TNF-a mRNA expres-
sion (Fig. 4B) compared to controls devoid of H2O2
(Fig. 4A). Conversely, addition of NAC, SN50 or allicin in
H2O2-challenged infected monocytes revealed a suppression
by 5 logs (P < 0.001), 7.7 logs (P < 0.001) and 8 logs
(P < 0.001), respectively, in comparison to corresponding con-
trol cultures. SN50/M failed to show any eﬀect on TNF-a
mRNA expression (Fig. 4B).
3.5. Glutathione peroxidase activity
GPx activity was determined in MTB-infected monocytes
co-cultured for 24 h with or without NAC, SN50, SN50/M
and allicin. Uninfected and MTB-infected but non-treated
monocytes served as controls. GPx activity was suppressedFig. 5. Determination of GPx activity. Human monocytes were
infected with MTB H37Rv (1:1 bacteria/cell). Some cultures were not
infected (MN only) and served as controls. Cultures then received
either NAC (10 mmol/l), SN50 (100 lg/ml), SN50/M (100 lg/ml),
allicin (500 ng/ml), H2O2 (10 nmol/l), NAC (10 mmol/l) + H2O2
(10 nmol/l), SN50 (100 lg/ml) + H2O2 (10 nmol/l), SN50/M (100 lg/
ml) + H2O2 (10 nmol/l) or allicin (500 ng/ml) + H2O2 (10 nmol/l). GPx
activity was determined in culture supernatants at 24 h. Data are mean
(±S.E.) of 4 experiments.
N. Hasan et al. / FEBS Letters 580 (2006) 2517–2522 2521by 41% (P < 0.001) in MTB-infected monocytes relative to
uninfected monocytes. Moreover, in comparison to MTB-in-
fected monocytes, addition of allicin (500 ng/ml), NAC
(10 mmol/l) and SN50 (100 lg/ml) enhanced the GPx activity
by 43%, 40% and 37% (P < 0.001 for all), respectively
(Fig. 5). Nearly similar trend in GPx activity was also observed
following H2O2 challenged MTB-infected monocytes that were
co-cultured with allicin, NAC and SN50, respectively (Fig. 5).
Thus, allicin proved to be a potent enhancer of GPx activity in
MTB-infected monocytes.4. Discussion
We have previously reported that MTB infection of mono-
nuclear phagocytes leads to activation of TNF-a gene, and
that cellular activation and enhancement of TNF-a and ROI
promotes MTB proliferation in host cells [17]. Based on these
ﬁnding, we probed here the management and/or regulation
of ROS and TNF-a activation in MTB-infected human
monocytes. The mechanisms of cellular activation as well as
TNF-a and ROS enhancement would deﬁnitely help in better
understanding the pathogenesis of tuberculosis. Thus, only the
host component was the subject of investigation.
TNF-a is implicated in both the pathophysiology and pro-
tective host response to MTB and other mycobacterial infec-
tions [24,25]. Elevated levels of TNF-a are present at the site
of MTB infection, and monocytes from tuberculosis patients
produce more TNF-a in vitro than those from uninfected do-
nors [26,27]. Moreover, ROS are also involved in the etiopa-
thology and promotion of tuberculosis. Radicals generated
in MTB-infected cells stimulate TNF-a, causing MTB prolifer-
ation.
We used allicin in the present study whose exact mechanism
underlying its antioxidant activity still remains poorly under-
stood. Allicin-induced enhancement of GPx activity has been
reported [28,29]. We show for the ﬁrst time that allicin exerts
potent anti-inﬂammatory eﬀects on host mononuclear cells in-
fected with MTB. Since higher doses of allicin (>100 lM) have
proven toxic [9], thus prior to all investigations, cell viability
and potential cytotoxicity were determined for the doses em-
ployed in this study using trypan blue and MTT assay where
viability of 98–99% was observed. Moreover, no eﬀect of alli-
cin was observed on housekeeping genes namely b-actin and
R18, thereby demonstrating that the eﬀect of allicin was not
mediated by cellular death, but rather by speciﬁc inhibition
of expression and secretion of pro-inﬂammatory molecules.
The results indicate an appreciable suppression in endoge-
nous TNF-a mRNA expression by 7.1 logs and 8.1 logs with
250 and 500 ng/ml of allicin, respectively, in MTB-infected
monocytes. TNF-a production in monocytes is regulated at
multiple intracellular levels, beginning with transcription [30].
The same is true in alveolar macrophages, as has been previ-
ously described by us [17]. Augmented expression of TNF-a
mRNA [31] and activation of a relevant transcription factor,
NF-jB [21], have been reported in monocytic cells treated with
MTB. Consistent with these ﬁnding, we also report the upreg-
ulation of TNF-a mRNA expression as well as activation of
NF-jB in human monocytes infected with MTB.
Induction of TNF-a expression was mediated through acti-
vation of NF-jB, as evidenced by the suppression of TNF-amRNA in the presence of SN50, an inhibitor of NF-jB.
SN50/M, an inactive analogue of SN50 failed to show any such
eﬀect. It has been well established that TNF-a induced nuclear
translocation of NF-jB was inhibited by SN50 peptide as dem-
onstrated in EMSA [23]. In view of it, our data demonstrated
that this eﬀect involved inhibition of the NF-jB pathway in-
duced by allicin probably by inhibiting the degradation of
IjBa. The NFjB heterodimer is retained in the cytoplasm in
an inactive form through association with one of the IjBs
inhibitory proteins. As a consequence of stimulation by
TNF-a, the IjBa gets phosphorylated by a speciﬁc kinase
complex (IKK) leading to its ubiquitination, and subsequent
proteolysis by the 28S proteosome [32,33]. The degradation
of IjB releases active NF-jB, which translocates to the nucleus
and regulates gene expression by binding to jB binding sites or
by interacting with other transcriptional factors [34]. Since a
number of genes involved in inﬂammatory responses are regu-
lated by NF-jB pathway, thus a high magnitude downregula-
tion of the NF-jB pathway by allicin would predictably reduce
the elaboration of NF-jB-mediated TNF-a mRNA expres-
sion. In addition, allicin exerted a higher degree of neutralizing
eﬀects than NAC and anti-TNF-a antibodies on TNF-a in-
duced actions in MTB-infected human monocytes.
Glutathione directly reacts with ROS, and GPx catalyzes the
removal of hydrogen peroxide [35]. Decrease in GPx activity
indicates impairment of hydrogen peroxide-neutralizing mech-
anisms [36]. Here, we observed a decline in GPx activity in
MTB-infected monocytes that were untreated or treated either
with H2O2, SN50/M or H2O2 + SN50/M, thereby correlating
with earlier reports that substantial amounts of ROS are being
generated in cells infected with MTB due to cellular activation
[17]. Enhancement of GPx activity in MTB-infected monocyte
cultures after addition of NAC, a precursor of in vivo antiox-
idant glutathione, indicates reversal of impaired neutralizing
mechanisms. Surprisingly, here slightly augmented GPx activ-
ity was observed when allicin was co-cultured instead of NAC,
indicating allicin to be an eﬀective natural antioxidant combat-
ing ROS, generated as a consequence of cellular activation in
MTB-infected mononuclear phagocytes. Thus, our study
shows enhanced GPx activity by allicin which correlated inver-
sely with the downregulation of TNF-amRNA expression and
ROS in monocytes infected with MTB.
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